Merit Medical Acquires Assets of Radial Assist

Published on:

Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired the assets of Radial Assist, which include the RAD BOARD(R), RAD BOARD(R)XTRA(TM), RAD TRAC(TM), and RAD REST(R) devices.

Financing for the $2.5 million transaction was provided by Wells Fargo Bank with an expansion of Merit's existing credit facility.

The RAD BOARD is designed to provide a larger work space for physicians and an area for patients to rest their arms during radial procedures.
The RAD BOARD XTRA is designed to work in conjunction with the RAD BOARD by extending the usable work space and allowing for a 90-degree perpendicular extension of the arm for physicians who prefer doing procedures at a 90-degree angle. The RAD TRAC is also designed to be used with the RAD BOARD and facilitates easy placement and removal of the RAD BOARD with the patient still on the table. The RAD REST is a disposable, single-use product designed to stabilize the arm by ergonomically supporting the elbow, forearm and wrist during radial procedures.

"We believe these products will assist us in our efforts to provide a complete offering for radial artery access procedures," said Fred P.
Lampropoulos, Merit's Chairman and CEO. "These products provide the necessary procedure set-up and enhance patient comfort."

CONFERENCE CALL

Merit will host a conference call to further discuss the details of this acquisition and the acquisition of the SAFEGUARD(R) Pressure Assisted Device and the AIR-BAND(TM) Radial Compression Device from Datascope Corp. today, October 7, 2013, at 4:00 p.m. Eastern (3:00 p.m.
Central, 2:00 p.m. Mountain, and 1:00 p.m. Pacific). The domestic phone number is (877) 941-9205 and the international number is (480) 629-9771. A live webcast as well as a rebroadcast of the conference call can be accessed through the Investors page at www.merit.com.

Related Content

What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.